Li Hu
Fujian Key Laboratory Of Translational Research In Cancer And Neurodegenerative Diseases
Fuzhou, China
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Activation of transient receptor potential vanilloid 1 ameliorates tau accumulation-induced synaptic damage and cognitive dysfunction via autophagy enhancement.
Journal: CNS neuroscience & therapeutics
Published: May 02, 2023
Ablation of Death-Associated Protein Kinase 1 Changes the Transcriptomic Profile and Alters Neural-Related Pathways in the Brain.
Journal: International journal of molecular sciences
Published: February 27, 2023
MiR-191-5p Attenuates Tau Phosphorylation, Aβ Generation, and Neuronal Cell Death by Regulating Death-Associated Protein Kinase 1.
Journal: ACS chemical neuroscience
Published: December 01, 2022
miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: May 31, 2022
Blocking ERK-DAPK1 Axis Attenuates Glutamate Excitotoxicity in Epilepsy.
Journal: International journal of molecular sciences
Published: April 12, 2022
Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer's disease.
Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer's disease.
Journal: Translational neurodegeneration
Published: December 27, 2021
Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease.
Journal: International journal of biological sciences
Published: September 02, 2021
Inhibition of Death-associated Protein Kinase 1 protects against Epileptic Seizures in mice.
Journal: International journal of biological sciences
Published: February 28, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026